United Therapeutics' legal victory; BMS' Camzyos approved for kids

RegulatoryapprovedCamzyosPositive

AI Analysis

Summary

United Therapeutics won a federal court ruling in Delaware, and Bristol Myers Squibb received FDA approval for Camzyos in pediatric patients. The article also mentions news from multiple other biotech companies.

Outcome Details

Camzyos approved for pediatric use

Importance:6/10

Sentiment:

0.50

regulatoryFDA approvallitigationpediatric indication

Related Companies

$UTHR $CELG-RI $ATRA

Read the original article

Published by Endpoints News on October 1, 2026 3:29 PM

Read Original